Answers are grounded in this paper and cite their sources.
Synthesis and enzymatic evaluation of new series of N(4)-substituted piperazine naphthamide derivatives as BACE-1 inhibitors for the treatment of Alzheimer's disease are reported.
No takes yet. Share an insight, caveat, or question.
Laras et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: